-
Nhau Dzinonakidza | China's Largest Semaglutide API Production Facility Inopfuura US FDA Inspection
Kubva Nyamavhuvhu 26 kusvika Nyamavhuvhu 30, 2024, nzvimbo yekugadzira peptide yeJYMed, Hubei JX Bio-Pharmaceutical Co., Ltd., yakabudirira kupasa ongororo yepasaiti yakaitwa neUS Food and Drug Administration (FDA). Ongororo iyi yakabata nzvimbo dzakakosha ...Verenga zvimwe -
2024 CPHI Milan Pharmaceutical Exhibition Recap
01. Exhibition Overview Musi wa8 Gumiguru, 2024 CPHI Worldwide Pharmaceutical Exhibition yakatanga muMilan. Sechimwe chezviitiko zvakakosha zvepagore muindasitiri yemishonga yepasi rose, yakakwezva vatori vechikamu kubva kunyika 166 nematunhu. Nekupfuura...Verenga zvimwe -
Nhau Dzinonakidza | JYMed's Liraglutide API Inogamuchira WC Chitupa
Musi waGumiguru 12, 2024, JYMed's Liraglutide API yakawana Chitupa Chakanyorwa Chisimbiso (WC), ichimaka nhanho yakakosha yekuenda kunze kwenyika kweAPI kumusika weEU. Iyo WC (Yakanyorwa Simbiso)...Verenga zvimwe -
Nhau Dzinonakidza: JYMed's Leuprorelin Acetate Inopfuura Kunyoresa Kunyoreswa Kwezvinodhaka
Munguva pfupi yapfuura, JYMed Technology Co., Ltd. yakazivisa kuti Leuprorelin Acetate, yakagadzirwa nerubatsiro rwayo Hubei JX Bio-Pharmaceutical Co., Ltd., yakabudirira kupasa kuongororwa kwekunyoresa zvinodhaka. Original Drug Market...Verenga zvimwe -
Makorokoto JYMed's Tirzepatide Inopedza US-DMF Kuisa
JYMed Technology Co., Ltd. iri kufara kuzivisa kuti chigadzirwa chayo, Tirzepatide, yabudirira kupedza kunyoreswa kweDrug Master File (DMF) neUS FDA (DMF Nhamba: 040115) uye yakagamuchira FDA's Kubvuma...Verenga zvimwe -
JYMed Inopinda PCT 2024 muShanghai
PCT2024 Personal Care Technology Summit & Exhibition chiitiko chine simba zvakanyanya mudunhu reAsia-Pacific, chakatarisana nekuchinjana tekinoroji uye kuratidzwa muindasitiri yezvigadzirwa zvekuchengeta.Verenga zvimwe -
JYMed Peptide inokukoka iwe kuti uende ku2024 Korea In-cosmetics Ingredients Exhibition.
Nzvimbo: Korea International Exhibition Center Date: Chikunguru 24-26, 2024 Nguva: 10:00 AM - 5:00 PM Kero: COEX Exhibition Center Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics ndiyo inotungamira boka rezviratidziro zvepasirese mune yekuchengeta munhu ...Verenga zvimwe -
New Regulation Bulletin
1. New FDA Registration Regulations yeUS Cosmetics Cosmetics Pasina FDA Registration Icharambidzwa Kutengeswa.According the Modernization of Cosmetics Regulation Act of 2022, yakasainwa nePresident Biden musi wa29 Zvita 2022, zvese zvekuzora zvinotumirwa kuUnited States zvinofanirwa kunge zviri FDA. -rejista...Verenga zvimwe -
Spring Festival Holiday Notice
Ndokumbira muziviswe kuti hofisi yedu ichavharwa kubva Kukadzi 4 kusvika Kukadzi 18 nekuda kweMutambo weChirimo. Chero mirairo ichagamuchirwa asi haizogadziriswi kusvika Kukadzi 19, zuva rebhizinesi rekutanga mushure meMutambo weChirimo. Tine urombo nekukanganisa kwaita.Verenga zvimwe -
2023 Iyo yechi88 API CHINA
Ruzivo nezve JYMed muna 2023 API CHINA 【pa-saiti】 Pasi pehutungamiriri hwaVice General Manager Zhi Qin, Shenzhen JYMed Technology Co.,Ltd. (inozonzi JYMed) yakapinda muchiratidziro chikuru ichi. JYMed yakaratidza zvigadzirwa zvinobatsira Semaglutide, Liraglutide, Tirzepatide, O...Verenga zvimwe -
Tikugashirei kusangana nesu pakuratidzira kweAPI paQindao China JYMed stock: N4K32
Verenga zvimwe -
JYMed yakasangana newe paPCHi
Mushure memakore maviri ekutarisira, 2023 China International Cosmetics Personal and Home Care Raw Materials Exhibition (PCHi) yakanga yaitirwa muGuangzhou Canton Fair Complex muna Kukadzi 15-17, 2023. ...Verenga zvimwe -
Semeglutide API yeShenzhen JYMed yakagamuchirwa neboka rekutanga reNMPA yemumba uye Yakanyoreswa muUS FDA (DMF No. 036009) ine chimiro "A".
Muna Chivabvu 2022, Shenzhen JYMed Technology Co., Ltd. (inozonzi JYMed peptide) yakaendesa chikumbiro chekunyoreswa semaglutide API kuUS Food and Drug Administration (FDA) (DMF nhamba yekunyoresa: 036009), Yapfuura. ongororo yekuvimbika, uye chimiro chazvino ini...Verenga zvimwe -
Copper Peptides: Ganda uye Bvudzi Kuchengeta Benefits uye Mashandisiro Azvo
Isu tinosanganisira zvigadzirwa zvatinofunga kuti vaverengi vedu vachawana zvinobatsira. Tinogona kuwana komisheni diki kana iwe ukatenga kuburikidza nekubatanidza pane ino peji. Iyi ndiyo nzira yedu. Mapeptides arikungoitika amino acids anobatsira kuburitsa collagen uye elastin, iwo maviri anobatanidza tishu ane chekuita ne ...Verenga zvimwe -
Ozempic (Semaglutide) Jekiseni: Zvishandiso, Side Effects, Dosage
Erica Prouty, PharmD, inyanzvi yemishonga inobatsira varwere nemishonga nemasevhisi emishonga muNorth Adams, Massachusetts. Mune zvidzidzo zvisiri zvevanhu zvemhuka, semaglutide yakaratidzwa kukonzera C-cell thyroid tumors mumakonzo. Nekudaro, hazvizivikanwe kana njodzi iyi inosvika kuvanhu....Verenga zvimwe -
Derivatization yemafuta acids mukuwanikwa kwepeptide uye mapuroteni zvinodhaka
Ndatenda nekushanyira Nature.com. Shanduro yebrowser yauri kushandisa ine tsigiro yeCSS shoma. Kuti uwane ruzivo rwakanyanya, tinokurudzira kuti ushandise browser yakagadziridzwa (kana kudzima Compatibility Mode muInternet Explorer). Zvichakadaro, kuti tive nechokwadi chekuenderera mberi nerutsigiro, isu tinopa saiti pasina s...Verenga zvimwe -
Kirasi I inovandudza mushonga weJYMed yafambira mberi zvakanyanya, Laipushutai inotarisirwa kuve mutsara wekutanga weUC mishonga.
Musi waChikumi 29, 2017, kuvandudzwa kweLaipushutai, kirasi I yemishonga yekuvandudza nekubatana kwekuvandudza kweJYMed neGuangzhou Linkhealth Medical Technology Co., Ltd., yakafambira mberi zvakanyanya. Chiziviso chemushonga IND chatambirwa neCFDA. JYMed uye Guangzhou Lin...Verenga zvimwe -
Nhau & ZviitikoIyo Peptide Zvigadzirwa Chikamu muJYMed yakapfuura zvisina mhosva pane-saiti kuongororwa kubva kuFDA.
Neushamwari kukorokotedza yedu Polypeptide Zvigadzirwa Chikamu nekubudirira kupasa iyo US FDA pa-saiti yekuongorora ne "zero defects"! Kupfuura iyo FDA pa-saiti yekuongorora ne "zero defects" chiitiko chikuru munhoroondo yedu yekusimudzira cGMP. Hazvirevi chete kuti API yedu ine obt...Verenga zvimwe